Materialise N.V.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Brigitte de Vet-Veithen
- Full Time Employees
- 2,556
- Sector
- Technology
- Industry
- Software - Application
- Address
- Technologielaan 15 Leuven VL Belgium 3001
- IPO Date
- Jun 25, 2014
- CIK
- 0001091223
- Website
- materialise.com
- Similar Companies
- Business
- Materialise NV (MTLS) engages in additive manufacturing software solutions, medical 3D printing applications, and industrial 3D printing services across the Americas, Europe, Africa, and Asia-Pacific. The company operates through three primary segments: Materialise Software, which provides platforms such as Magics for build preparation, Mimics for medical image processing, and Streamics for workflow management that interface with 3D printers, CAD/CAM software, and scanners to serve machine manufacturers, automotive, aerospace, consumer goods, and hearing aid producers; Materialise Medical, which delivers FDA-cleared software for image-based planning, patient-specific anatomical models, surgical guides, implants, and biomechanical analysis targeting hospitals, surgeons, medical device firms, and research institutions; and Materialise Manufacturing, which offers 3D printing services, rapid prototyping, design engineering, and production parts using diverse materials and technologies for automotive, aerospace, consumer goods, semiconductor, art, architecture, and industrial markets. Founded in 1990 and headquartered in Leuven, Belgium, Materialise maintains collaboration agreements with partners including Zimmer Biomet Holdings, DePuy Synthes, Medtronic, Smith & Nephew, and Abbott Laboratories. Recent developments include the July 2024 acquisition of FEops to integrate AI-driven simulation technology into its Mimics Planner for enhanced cardiovascular procedure planning and mass personalization in structural heart interventions; a strategic partnership with nTop announced in June 2024 to process complex geometries for serial end-use parts production; the Q1 2024 launch of e-Stage for Metal software with initial sales and a new qualified partner collaboration with EOS in Q2 2024; and the October 2025 merger of its i.materialise and Materialise OnSite platforms into a unified 3D printing service offering.
Company News
Materialise Q2 Earnings Call Highlights
Materialise NV (MTLS) Q2 2026 Earnings Call Transcript
Materialise Q2 Earnings Call Highlights
Materialise Reports Second Quarter and Half-Year 2026 Results
Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026
Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions
MATERIALISE NV RESULTS OF ANNUAL GENERAL SHAREHOLDERS' MEETING OF 16 JUNE 2026
All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy
Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge
Are Investors Undervaluing Materialise (MTLS) Right Now?
Materialise Q1 Earnings Call Highlights
Materialise NV (MTLS) Q1 2026 Earnings Call Transcript
Materialise Reports First Quarter 2026 Results
Materialise: The Medical Segment Alone Makes This A Buy
Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026
Materialise to Transfer RapidFit Business to Its Management Team
Materialise (NASDAQ:MTLS) Stock Crosses Below Fifty Day Moving Average – Here’s What Happened
Materialise: Medical And Software-Led Rebound
Materialise NV (MTLS) Q4 2025 Earnings Call Transcript
Materialise Reports Fourth Quarter and Full Year 2025 Results